Finch, Robert

RONALD F. COBURN, University of Pennsylvania School of Medicine, Philadelphia T. TIMOTHY CROCKER, University of California College of Medicine, Irvine CLEMENT A. FINCH, University of Washington, Seattle SHELDON K. FRIEDLANDER, California Institute of Technolc, Pasadena ROBERT I. HENKIN, Georgetown University Hospital, Washington, D.C. 

Upjohn filed suit in the U.S. District Court of the Western District of Michigan to stop the FDA from removing the drugs and named Robert H. Finch, secretary of health, education, and welfare, and Herbert L. Ley, commissioner of the FDA, as defendants. With sales of the drugs reaching 30 million a year, Upjohn had a considerable stake in the case. The district judge issued an injunction to prevent the FDA from enforcing its order and then considered the merits of the suit. 

Roberts LJ, Finch PM, Goucke CR, Price LM. Outcome of intrathecal opioids in chronic non-cancer pain. Eur J Pain 2001 5(4) 353-61. 

Roberts LJ, Finch PM, Pnllan PT, Bhagat Cl, Price LM. Sex hormone snppression by intrathecal opioids a prospective study. Clin J Pain 2002 18(3) 144-8. 

Angela M. Finch, Valerie Sarramegna, and Robert M. Graham... 

Annual variations in trace elements are now known to be a normal feature of caves in shallow karst environments (Roberts et al., 1998 Fairchild et al., 2001 Finch et al., 2001 Huang et al., 2001 Fairchild, 2002) and subannual variations can also be observed where speleothems grow sufficiently quickly. These variations can be related mainly either to changes in the ion ratios in solution in relation to hydrological effects, or to seasonal changes in supersaturation of karst waters, that is the same two controls that are responsible for petrographic laminae. In section 7.6.2, such variations are related to potential controlling factors. 

---